NASDAQ · Analyst Forecast

Mustang Bio, Inc. (MBIO) Stock Forecast & Price Target

$0.39 NASDAQ: MBIO Market Cap $2.63M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Mustang Bio, Inc. (MBIO), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Mustang Bio, Inc., analysts forecast revenue rising from $50,000 in 2018 to $55.60M in 2027; the average estimate for 2027 earnings per share is −$51.50; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2018$50,000$50,000$50,0001
2025$0$0$01
2026$11.00M$11.00M$11.00M1
2027$55.60M$55.60M$55.60M1

Earnings per share forecast

YearLowAverageHighAnalysts
2018−$735.00−$735.00−$735.001
2025−$17.50−$17.50−$17.501
2026−$99.00−$99.00−$99.001
2027−$51.50−$51.50−$51.501

Mustang Bio, Inc. (MBIO) forecast — frequently asked questions

What are analysts forecasting for Mustang Bio, Inc.'s earnings?

The average analyst estimate for Mustang Bio, Inc. (MBIO) earnings per share in 2027 is -51.50, with individual estimates between -51.50 and -51.50.

How much revenue is Mustang Bio, Inc. expected to make?

Analysts forecast Mustang Bio, Inc. (MBIO) revenue of $55.60M in 2027, based on 1 published estimates.

How many analysts cover MBIO?

1 analyst contribute estimates for Mustang Bio, Inc. (MBIO). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.